Close

CRY1

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

CRY1 (Cryptochrome Circadian Regulator 1) is a Protein Coding gene. Diseases associated with CRY1 include Delayed Sleep Phase Disorder and Retinitis Pigmentosa 59. Among its related pathways are Melatonin metabolism and effects and Circadian rythm related genes. Gene Ontology (GO) annotations related to this gene include nucleotide binding and transcription factor binding. An important paralog of this gene is CRY2.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-CQ0623 Anti-CRY1 (CBXC-2116) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXC-2116 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ0624 Anti-CRY1 (CBXC-2293) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXC-2293 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ0625 Anti-CRY1 (CBXC-0573) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXC-0573 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4047 Anti-CRY1 (CBXC-2116) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXC-2116 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4048 Anti-CRY1 (CBXC-2293) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXC-2293 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4049 Anti-CRY1 (CBXC-0573) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXC-0573 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.